FDA official says UniQure fell short on Huntington's trial, defends new study request - Reuters
FDA official says UniQure fell short on Huntington's trial, defends new study request Reuters
Results for “UniQure”
7 stories found
Finance3d ago
uniQure GAAP EPS of -$3.46 beats by $0.46, revenue of $16.1M misses by $0.3M
uniQure falls after FDA commissioner’s comments on rare disease therapy
UniQure slides after FDA says trial data insufficient for brain disorder therapy filing - TradingView
UniQure slides after FDA says trial data insufficient for brain disorder therapy filing TradingView
Analyst Ratings and Price Target Updates for Various Biotech and Pharmaceutical Companies
Several financial firms have issued new ratings, price targets, or coverage initiations for biotech and pharmaceutical companies including Beam Therapeutics, Krystal Biotech, 4D Molecular Therapeutics, BioMarin Pharmaceutical, Vertex Pharmaceuticals, CRISPR Therapeutics AG, Regeneron Pharmaceuticals, and UniQure.
US Premarket Movers: AES, Amazon, American Air, Exxon, UniQure
Several companies, including AES, Amazon, American Air, Exxon, and UniQure, are identified as significant movers in the US premarket trading.
uniQure Q4 2025 Earnings Preview
An article provides a preview of uniQure's upcoming fourth-quarter 2025 earnings report, outlining expectations for the biotechnology company's financial performance.